Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients

Figure 2

Distribution of CD8+ T cell responders to Her-2 according to tumour stage. Percentage of CD8+ T cell responders to Her-2 are significantly higher in patients with tumour stage 0,1 (T 0,1) compared to the patients with tumour stage 3,4 (T 3,4). Her2, human epidermal growth factor receptor 2.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us